- Research article
- Open Access
TbAGO1, an Argonaute protein required for RNA interference, is involved in mitosis and chromosome segregation in Trypanosoma brucei
BMC Biologyvolume 1, Article number: 2 (2003)
RNA silencing processes are widespread in almost all eukaryotic organisms. They have various functions including genome protection, and the control of gene expression, development and heterochromatin formation. RNA interference (RNAi) is the post-transcriptional destruction of RNA, which is mediated by a ribonucleoprotein complex that contains, among several components, RNA helicases and Argonaute proteins. RNAi is functional in trypanosomes, protozoan parasites that separated very early from the main eukaryotic lineage and exhibit several intriguing features in terms of the control of gene expression. In this report, we investigated the functions of RNAi in Trypanosoma brucei.
By searching through genome databases, novel Argonaute-like proteins were identified in several protozoa that belong to the kinetoplastid order, a group of organisms that diverged early from the main eukaryotic lineage. T. brucei possesses two Argonaute-like genes termed TbAGO1 and TbPWI1. Dual transient transfection assays suggest that TbAGO1, but not TbPWI1, is involved in RNAi. The entire coding region of TbAGO1 was deleted by double gene knockout. TbAGO1-/- cells turned out to be completely resistant to RNAi generated either by transfected double-stranded RNA or by expression of an inverted repeat. TbAGO1-/- cells were viable but showed a dramatically reduced growth rate. This was probably due to defects in mitosis and abnormal chromosome segregation as revealed by in situ analysis. The RNAi and growth phenotypes were complemented by the inducible expression of a GFP::TbAGO1 fusion protein that revealed the cytoplasmic location of the protein.
The requirement of TbAGO1 for RNAi in trypanosomes demonstrates the evolutionary ancient involvement of Argonaute proteins in RNAi silencing processes. RNAi-deficient TbAGO1-/- cells showed numerous defects in chromosome segregation and mitotic spindle assembly. We propose a working hypothesis in which RNAi would be involved in heterochromatin formation at the centromere and therefore in chromosome segregation.
RNA silencing includes a wide range of post-transcriptional phenomena in eukaryotes, such as post-transcriptional gene silencing in plants , quelling in fungi , homology-dependent gene silencing in ciliates  and RNA interference (RNAi) in animals . The latter is a process in which the presence of double-stranded RNA (dsRNA) of a given sequence induces the rapid, efficient and specific degradation of the mRNA with the corresponding sequence. In most cases, long dsRNA is fragmented into 21 – 26 bp dsRNAs, termed short interfering RNAs (siRNAs) , by the action of Dicer, a type III ribonuclease . These siRNAs are part of an enzymatic complex that scan RNA and target those with the identical sequence to that of the siRNAs for destruction. Other types of proteins involved in RNAi include RNA helicases, Argonaute proteins, and, in some species, RNA-dependent RNA polymerases . Mechanistic aspects of RNA silencing are remarkably well conserved among organisms as diverse as protists, fungi, plants and animals, indicating that it has important functions. One such function appears to be the protection of the genome from unwanted nucleic acids, such as those expressed by viruses in plants [8, 9], or those originating from transposons [10, 11]. Additional functions have been unveiled, such as the control of gene expression during development , genome rearrangement in ciliates [13, 14] and the formation of heterochromatin and control of gene expression in plants and fission yeast [15–17].
Trypanosomes are protozoan parasites belonging to the order Kinetoplastida, which diverged very early from the main eukaryotic lineage. These unicellular organisms are responsible for several tropical diseases including sleeping sickness in central Africa, which is caused by the species Trypanosoma brucei. This species is found alternately in the digestive tract of an insect vector, the tsetse fly, and the bloodstream of a mammalian host. It adapts to these different environments by activating specific programs of differentiation . Trypanosomes develop as extracellular parasites and escape the host immune response by means of a sophisticated process of antigenic variation. Their surface is entirely covered by a dense coat composed of a single type of molecule, the variant surface glycoprotein (VSG). Trypanosomes possess several hundreds of VSG genes scattered throughout their genome but these can only be expressed from one of ~20 expression sites, with only a single site being active at one time .
Trypanosomes were among the first organisms in which RNAi was identified. RNAi was detected in mutants expressing dsRNA of genes coding for the paraflagellar rod A protein (PFRA)  and for tubulin . RNAi was rapidly exploited as a powerful tool for the study of gene function [22–26]. As in other organisms, long dsRNAs are degraded into siRNAs and incorporated into a ribonucleoprotein complex . About 10 – 20 % of siRNAs are associated with translating polyribosomes, suggesting a possible interaction between RNAi and the translation machinery . Cloning and sequencing of trypanosome siRNA has revealed a large number of endogenous short RNAs corresponding to the INGI and SLACS retroposon elements, suggesting that one function of RNAi could be the control of mobile genetic elements . Interestingly, such mobile elements are missing from the genome of the related parasite Leishmania, where RNAi does not seem to be functional .
To evaluate the role of RNAi in the control of gene expression and in the general biology of trypanosomes, we searched for molecular components of the RNAi machinery and investigated their function. We identified two Argonaute proteins, TbAGO1 and TbPWI1 and demonstrate that the first is essential for RNAi. Moreover, we show that cells deprived of TbAGO1 display numerous defects in chromosome segregation and mitotic spindle assembly. Finally, we propose a working model to explain the observed results.
Identification of new Argonaute proteins
In order to investigate RNAi functions in trypanosomes, we first searched candidate genes potentially involved in this mechanism. We screened various protist genome databases with the sequence of genes known to be involved in RNAi in other organisms. The genomes analysed were from T. brucei, T. cruzi and Leishmania major (all belonging to the order Kinetoplastida), from Giardia lamblia and from Plasmodium falciparum. Two distinct Argonaute-like proteins, TbAGO1 and TbPWI1, were identified in T. brucei whereas single proteins were found in G. lamblia (GlAGO1), T. cruzi (TcPWI1) and L. major (LmPWI1). Searches through the complete genome sequence of P. falciparum failed to identify any Argonaute-like genes. These proteins were examined for the presence of motifs and aligned with other members of the Argonaute protein family from several eukaryotic species (Fig. 1A). TbAGO1 is a protein of 892 amino acids, with a calculated molecular weight of 98015 Da and with an estimated pI of 9.18. It possesses a PAZ and a Piwi domain, typical signatures of Argonaute proteins . The Piwi domain shows 20 – 31 % homology with Piwi domains of Argonaute proteins from other species (see Additional file: 1), whereas the PAZ domain shows weaker conservation. In addition, TbAGO1 contains an amino-terminal RGG box (a nucleic acid-binding domain), with 10 copies of the arginine-glycine-glycine motif. This feature has not been observed previously in Argonaute proteins from other species. However, detailed analysis of the poly-glutamine (poly-Q) box present at the amino-terminal end of the Arabidopsis thaliana AGO1 protein revealed the presence of five copies of the RGG motif (Fig. 1B).
TbPWI1 and LmPWI1 contain a typical Piwi domain, but no PAZ domain could be recognised. Neither possesses an RGG box. These two proteins show high homology in their Piwi domain (55.4% identity), with a specific insertion that is not found in Argonaute proteins from other organisms (see supplementary data).
TbAGO1, but not TbPWI1, is required for RNAi
We explored whether TbAGO1 and TbPWI1 are involved in RNAi silencing in T. brucei. Since trypanosomes display different life cycle stages, each with a specific pattern of protein expression, we first checked whether TbAGO1 and TbPWI1 were expressed in the procyclic culture stage used for this study. Real time PCR analysis (Fig. 1C) showed that RNA for both TbAGO1 and TbPWI1 were expressed in this stage.
To evaluate the possible participation of TbAGO1 and TbPWI1 in RNAi in trypanosomes, we used a double transient transfection assay as developed in Drosophila [6, 31]. Trypanosomes were first transfected with dsRNA targeting RNA coding for proteins potentially involved in RNAi and returned to culture for 10 h. To evaluate the consequences of silencing the candidate protein on the behaviour of the RNAi machinery, a second dsRNA targeting a marker gene was introduced. We selected the PFRA gene as a marker: this gene codes for an abundant flagellar protein that is essential for cell motility . Loss of PFRA via RNAi produces a viable and obvious paralysis phenotype that can easily be monitored by immunofluorescence [22, 32]. Candidate genes included TbAGO1 and TbPWI1, as well as green fluorescent protein (GFP) as a control. Transfection of GFP dsRNA did not modify the ability of PFRA dsRNA to subsequently silence PFRA expression, producing the usual number of paralysed trypanosomes (Fig. 2A). In contrast, the introduction of TbAGO1 dsRNA led to a five-fold reduction in the efficiency of RNAi generated by PFRA dsRNA. Electroporation of TbPWI1 dsRNA led to normal PFRA silencing (Fig. 2A). These results were reproduced six times, including with two different markers (tubulin and flagellum adhesion glycoprotein-1 [FLA1]). These data suggest that TbAGO1, but not TbPWI1, is involved in RNAi.
To confirm that the observed reduction in RNAi silencing activity was due to the knockdown of TbAGO1 RNA and protein, we generated a cell line expressing TbAGO1 fused to GFP under the control of a tetracycline-inducible promoter (Fig. 3A). We fused the GFP gene upstream of TbAGO1 as downstream fusions have turned out to be non-functional in other organisms . This construct allows monitoring of the TbAGO1 silencing effect by visualisation of the GFP::TbAGO1 fluorescent protein. The cell line expressing the GFP::TbAGO1 protein was transfected with TbAGO1 dsRNA or with dsRNA from the unrelated TbGRP1 gene as control. GFP dsRNA could not be used as a control in this experiment as the GFP gene was fused to TbAGO1. Cells were returned to culture for 10 h and then transfected with PFRA dsRNA. FACS analysis revealed a ~10-fold reduction of GFP::TbAGO1 fluorescence after introduction of TbAGO1 dsRNA, confirming that TbAGO1 is at least partially silenced during the assay (Fig. 2B). In these conditions, PFRA silencing was strongly diminished (Fig. 2B, inset), reproducing the results obtained with wild type (WT) cells (Fig. 2A). In contrast, cells electroporated with the control TbGRP1 dsRNA did not show any reduction in their GFP::TbAGO1 fluorescence signal compared with untransfected controls, and subsequent introduction of PFRA dsRNA produced the usual PFRA silencing effect (Fig. 2B). These data indicate that the observed inhibition of RNAi silencing was indeed due to the reduction in TbAGO1 abundance.
Since RNAi effects rarely last more two generations under these conditions, the transient nature of this type of experiment, and the difficulty of using RNAi silencing to study RNAi processes restricted further investigation. Having demonstrated the importance of TbAGO1 for RNAi, we decided to delete TbAGO1 by double gene knockout.
Deletion of TbAGO1 completely inhibits RNAi
Data from the T. brucei genome sequencing project, as well as our Southern blotting analysis (data not shown) showed that TbAGO1 is a single copy gene. As trypanosomes are diploid organisms, we produced two separate constructs for targeted gene replacement of the whole coding sequence of TbAGO1 by the drug resistance markers blasticidin S deaminase (BSD) and neomycin phosphotransferase (NEO) (Fig. 3A). The first allele of TbAGO1 was replaced by the BSD marker before the obtained cell line was transfected with the NEO construct to replace the second allele. Viable double-resistant cells were obtained and further characterised. Southern blotting (Fig. 3B) and PCR analysis (data not shown) of genomic DNA from the double-resistant cells confirmed that both constructs had integrated at the expected locus and that all endogenous copies of TbAGO1 had been deleted. The cell line was subcloned and termed TbAGO1-/-. TbAGO1-/- cells were further transfected with plasmid pGFPTbAGO1430 for expression of the fusion protein GFP::TbAGO1 in order to attempt functional complementation experiments (Fig. 3A). As the GFP::TbAGO1 fusion gene in this plasmid is expressed via a tetracycline-inducible promoter, we further transformed these cells with plasmid pHD360  that expresses the tet-repressor, allowing tetracycline-inducible control of expression of GFP::TbAGO1. The cell line was named TbAGO1-/-+GFP::TbAGO1 Ti. Northern blotting analysis confirmed that the GFP::TbAGO1 RNA was expressed in the presence of tetracycline (Fig. 3C). Fluorescence-activated cell sorter (FACS) analysis demonstrated that the GFP::TbAGO1 protein was only expressed in the presence of tetracycline (Fig. 4A).
To determine the involvement of TbAGO1 in RNAi, WT, TbAGO1-/- and TbAGO1-/-+GFP::TbAGO1 Ticells grown either in the presence or absence of tetracycline were transfected with PFRA dsRNA (Fig. 4B) or with tubulin dsRNA (data not shown). Immunofluorescence analysis with a PFRA-specific antibody failed to detect a single cell with reduced PFRA abundance. Therefore, RNAi silencing was completely abolished in the knockout cell line, demonstrating that TbAGO1 was essential for RNAi. A similar result was observed in the TbAGO1-/-+GFP::TbAGO1 Ticell line as long as the fusion protein was not expressed. In contrast, expression of GFP::TbAGO1 was sufficient to restore PFRA silencing (Fig. 4B), therefore complementing the phenotype and confirming that TbAGO1 is required for RNAi in trypanosomes. Similarly, when TbAGO1-/- cells were transfected with plasmid pααPFRA430, expressing a PFRA dsRNA as a hairpin , no PFRA silencing at all could be observed (data not shown). These data demonstrate that TbAGO1 is required for RNAi generated both by endogenously-expressed hairpin dsRNA and by exogenously dsRNA synthesised in vitro.
RNAi-deficient trypanosomes show mitotic defects
Although TbAGO1-/- cells were viable, they showed reduced growth rate and morphological defects. The doubling time of the knockout cell line was ~15 h as opposed to 8–9 h for WT or complemented cells (Fig. 5A). In an effort to understand the reduced growth rate of mutant cells, we monitored their cell biological behaviour. During the cell cycle, trypanosomes need to replicate two single unit genomes: the nuclear and the mitochondrial genomes . Trypanosomes possess a single mitochondrion, the kinetoplast, which contains a large DNA network that is visible under light microscopy. The kinetoplast duplicates first, followed by the nucleus, defining three cell cycle stages: cells with one kinetoplast and one nucleus (1K1N), cells with two kinetoplasts and one nucleus (2K1N) and cells with two kinetoplasts and two nuclei (2K2N) [35, 36]. Cultures of TbAGO1-/- cells showed normal proportions of these three sub-populations compared to WT or TbAGO1-/-+GFP::TbAGO1 Ticells grown in the presence of tetracycline (Fig. 5B), despite the presence of discrete modifications. However, TbAGO1-/- cultures exhibited a >30-fold increase in the proportion of cells with one kinetoplast but with no nucleus, also called zoids [37, 38], and a >20-fold increase in the proportion of cells with one kinetoplast but with two nuclei (Fig. 5B). These cell types are rare in normal, healthy cultures and are the consequences of a defect in nuclear mitosis. The classic nuclear mitosis / cytokinesis checkpoint is absent in trypanosomes, where cytokinesis is linked to kinetoplast duplication and segregation . Therefore cells with delayed nuclear mitosis that have managed to duplicate and segregate their kinetoplasts can undergo cytokinesis to produce one daughter cell without a nucleus but with a kinetoplast and another daughter cell with a kinetoplast and one or two nuclei, if mitosis can be completed.
These results indicate potential mitosis defects in TbAGO1-/- cells. We therefore examined the state of mitotic cells in cultures from WT, TbAGO1-/- and TbAGO1-/-+GFP::TbAGO1 Ticells grown in the presence of tetracycline (Fig. 6). Trypanosomes were fixed and stained with 4',6'-diamidino-2-phenylindole (DAPI) to visualise kinetoplast and nuclear DNA and with the anti-tubulin KMX-1 antibody to identify the mitotic spindle. In WT trypanosomes, mitotic cells are identified by the presence of a large nucleus and two well-separated kinetoplasts (2K1N cells). The mitotic spindle is easily recognisable, stretching in the direction of the long axis of the cells (Fig. 6, top panel). The vast majority of such 2K1N wild-type cells displayed a normal spindle (Table 1), as expected from previous observations . In contrast, more than 20 % of the TbAGO1-/- cells at the 2K1N stage did not possess a recognisable spindle at all, and of those with a spindle, almost half displayed various abnormalities (Fig. 6 and Table 1). In many cases, the spindle was not fully assembled and failed to show the typical elongation seen in WT trypanosomes. For example, the TbAGO1-/- cell shown on the central panel of Fig. 6 is at the same stage of its cell cycle as its WT counterpart shown on the top panel, judging from the distance separating the two kinetoplasts. Intriguingly, in the knockout cell, the spindle was barely formed, being very short and with no recognisable spindle poles when compared with the WT cell in the top panel. Another frequent defect was the presence of a large bent spindle, showing a bundle of microtubules present on only one side of the nucleus (Fig. 6, bottom panel). In several cases, the DNA staining pattern of the mitotic nucleus also looked unusual. Instead of a large, relatively homogenous amount of DNA (trypanosome chromosomes do not condense at mitosis), patches of disperse intense staining were frequently observed (Fig. 6, central panel).
The above data suggest significant mitotic defects in the TbAGO1-/- cell line. To assess whether nuclear segregation was complete, we used the monoclonal antibody L1C6, which recognises an unknown antigen localised to the nucleolus (L. Kohl and K. Gull, unpublished observations). In trypanosomes, the nucleolus is not dispersed at mitosis, which is intranuclear, but it is segregated along the mitotic spindle. In non-mitotic WT cells, this antibody stained the nucleolus, producing one bright spot per nucleus (data not shown). During early anaphase, the signal looked like a bright bar (Fig. 7A, left), corresponding to the nucleolus that is being segregated, since the nucleolus and nuclear membrane remain present throughout the trypanosome cell cycle. At telophase, both nuclei contained a well-defined nucleolus, recognisable as a bright spot (Fig. 7A, centre and right). Observation of binucleated cells of the TbAGO1-/- mutant revealed that one third of them displayed unequal distribution of the L1C6 nucleolar marker, suggesting that nuclei did not inherit the same amount of nucleolar material (Table 1 and Fig. 7B). In some cells, spots of staining appeared in the cytoplasm between the two nuclei, suggesting delayed or lost material (Fig. 7B, central panels). In addition, DAPI staining showed that the two nuclei often had different morphologies (Fig. 7B, right panels).
Further observations of DAPI staining in binucleated cells from the TbAGO1-/- mutant revealed the presence of lagging DNA material during mitosis (Fig. 7B and data not shown). These data suggest possible difficulties in chromosome segregation, a defect previously reported in yeast RNAi mutants [40, 41]. To evaluate this possibility, we performed fluorescence in situ hybridisation (FISH), using a probe recognising the tandem repeats of 5S ribosomal DNA, to visualise chromosome I at mitosis . In WT trypanosomes, two spots could be identified in G1 cells (Fig. 8A). Progression through mitosis can be monitored by DAPI staining using both nuclear and mitochondrial genomes as markers . In early (Fig. 8B) and late (Fig. 8C) anaphase, WT cells showed four spots migrating towards the spindle poles, reproducing published findings . In contrast, this pattern was frequently modified in TbAGO1-/- mitotic cells (Fig. 8D,8E,8F). Judging from the distance separating the two kinetoplasts, the TbAGO1-/- cell shown in Fig. 8D is at the same stage of the cell cycle as its WT counterpart presented in Fig. 8B. However, chromosome I segregation appeared to be delayed, with all the chromosomes found in the centre of the mitotic spindle. This defect was the most frequent in TbAGO1-/- mitotic cells. In other cases, unequal chromosome segregation was observed, with three chromosomes migrating towards one pole of the spindle and only one towards the opposite pole (Fig. 8E). In more remarkable cases, DAPI staining revealed the presence of several DNA entities containing variable numbers of chromosome I (Fig. 8F). These data strongly suggest that, in addition to spindle formation defects and to nucleolar segregation defects, chromosome segregation is also affected in the absence of TbAGO1. Taken together, these data indicate that the growth delay measured in the TbAGO1-/- mutant is very likely to be due to a mitotic defect and suggest a possible involvement of the RNAi machinery in this process.
Finally, as the GFP::TbAGO1 fusion protein is functional as it is able to complement the double mutant, it can be used as a tool to determine TbAGO1 localisation. Direct observation of live TbAGO1-/-+GFP::TbAGO1 Ticells grown in the presence of tetracycline without any fixative under the microscope revealed that the GFP::TbAGO1 fusion protein was mostly cytoplasmic (Fig. 9). However, some redistribution seemed to occur at mitosis, when the protein was concentrated around the nucleus and it was spread between the two nuclei at the end of mitosis. A similar distribution was observed at different levels of induction, irrespective of the amount of GFP::TbAGO1 fusion protein present.
Identification of novel Argonaute proteins
Searches through protist genome databases identified four novel Argonaute protein members: TbAGO1 and TbPWI1 in T. brucei, TcPWI1 in T. cruzi, LmPWI1 in L. major and GlAGO1 in G. lamblia. These protists belong to the orders Kinetoplastida and Diplomononida, which diverged very early from the main eukaryotic lineage, revealing the ancient origin of the Argonaute proteins. Since genome sequencing of these organisms has not yet been completed, other members of the Argonaute family may be uncovered. We could not identify any Argonaute protein in the database of P. falciparum or in other Plasmodium species, although genome sequencing is complete. Plasmodium is a parasite that belongs to the apicomplexan group that appeared later than kinetoplastids in evolution. It is possible that Argonaute proteins have been lost in this group, as they have in the budding yeast Saccharomyces cerevisae . Alternatively, they could have diverged too much to be recognised by conventional BLAST searches, especially since the genome of Plasmodium species is AT-biased.
All four proteins contained a typical Piwi domain , one of the signatures of the Argonaute protein family. The function of this domain is unknown but deletion experiments in mammalian cells suggest that it could be involved in interactions with the type III ribonuclease Dicer . The PAZ motif usually shows weaker conservation [13, 45] and could only be unambiguously identified in TbAGO1. The function of this domain is also unknown, although interestingly, it is present in Dicer . The PRP motif, identified in the mammalian Argonaute subfamily eIF2C , could not be found in any of the four protist Argonaute proteins, suggesting that it appeared later in the evolution of multicellular organisms.
In addition to PAZ and Piwi domains, TbAGO1 possesses an RGG box, containing 10 copies of the arginine-glycine-glycine motif in the first 60 amino acids. This motif is involved in nucleic acid binding and has been identified in numerous proteins including nucleolin and the helicase Vasa. RNA binding proteins bearing RGG motifs have already been identified in the T. brucei proteins NOP40/44, a nucleolar protein  and the mitochondrial protein RBP16 . In the latter case, extensive arginine methylation of RBP16 has been demonstrated, although its function remains to be determined .
TbAGO1 is required for RNAi
Dual transient transfection assays and TbAGO1 gene deletion followed by transformation or endogenous expression of dsRNA clearly demonstrated that TbAGO1, but not TbPWI1 is required for RNAi. This shows that the two proteins are not redundant, since TbPWI1 could not substitute for TbAGO1 in any of the RNAi assays we used. Similarly, inactivation of Caenorhabditis elegans RDE1 abolishes RNAi completely despite the presence of at least 22 other Argonaute members in the genome [11, 12]. Interestingly, Leishmania is not able to carry out RNAi  and possesses only a single Argonaute gene, LmPWI1 that is much closer to TbPWI1 than to TbAGO1.
A role for Argonaute proteins in RNA silencing processes has been shown in C. elegans , Neurospora crassa  and A. thaliana  by direct mutagenesis, and in D. melanogaster after purification of a ribonucleoprotein complex involved in RNAi, followed by functional characterisation in double transient transfection assays . Involvement of the four mammalian Argonaute proteins of the eIF2C subfamily has also been shown by double transfection assays, this time using siRNA . Trypanosomes are the first organisms for which a full knockout of an Argonaute protein involved in RNAi has been reported.
It is not yet clear how Argonaute proteins participate in RNAi. It should be noted that three of the Argonaute proteins proven to be involved in RNAi (AtAGO1, DmAGO2 and TbAGO1) possess amino-terminal extensions. The RGG box of TbAGO1 could be involved in RNA binding activities, supporting the hypothesis that Argonaute proteins could retain RNA molecules in the RNAi complex [28, 50]. Interestingly, several RGG motifs are also present in the poly-Q box of A. thaliana (Fig. 1B), although no mutants affecting this domain have yet been reported [49, 51].
TbAGO1 is required for proper chromosome segregation
Despite being completely resistant to RNAi generated by exogenous (in vitro synthesised) dsRNA or by endogenous (expressed hairpin) dsRNA, TbAGO1-/- mutant cells are viable, showing that RNAi activity is dispensable for procyclic trypanosomes in culture. Similarly, several mutants of the RNAi pathway in N. crassa, A. thaliana and C. elegans survive normally under laboratory conditions [2, 8, 9, 11]. A noticeable exception is found in A. thaliana where mutations in the AGO1 gene have severe consequences on both RNA silencing and development [49, 51]. In trypanosomes, detailed analysis demonstrated that TbAGO1-/- mutant cells encountered significant difficulties in cell cycle progression, resulting in reduced growth rate. Four lines of evidence indicated that the Argonaute protein is essential for mitosis and proper chromosome segregation in T. brucei. Firstly, the mutant showed a 20–30-fold increase of zoids and 1K2N cells, aberrant cell types typical of problems with mitosis such as those caused by the microtubule inhibitor rhizoxin [37, 38]. Treatment of WT trypanosomes with low concentrations of this drug selectively interferes with spindle formation, resulting in severe deficits in mitosis. However, mitochondrial genome duplication and segregation are not affected and cytokinesis can occur. This produces progeny with one kinetoplast but without a nucleus (zoids), and progeny with either one kinetoplast and one nucleus (if mitosis is completely inhibited) or with one kinetoplast and two nuclei (if mitosis is perturbed but not abolished). Significant production of zoids is also observed when mitosis progression is inhibited via RNAi targeting either cyclins or proteasome components potentially involved in cyclin control [52–54]. A delay in mitosis is further corroborated by the observation that, in the mutant TbAGO1-/- cell line, the proportion of 2K1N cells is increased, whereas that of 2K2N cells is reduced (Fig. 5B). Secondly, the spindle was frequently not recognisable in mitotic mutant cells and, when present, it exhibited significant defects in formation, being too short, without poles or bent. Thirdly, following mitosis, around one third of the binucleated mutant cells showed an unequal distribution of a nucleolar marker. Fourthly, and most significantly, FISH analysis revealed frequent chromosome segregation defects in TbAGO1-/- mitotic cells. Taken together with the presence of lagging DNA material and the frequent occurrence of apparently unequal DNA amounts in the two nuclei following mitosis, these data indicate significant problems in chromosome segregation and nuclear mitosis. It now remains to be seen whether these defects are related to the inability to carry out RNAi or to another function performed by TbAGO1.
These results are reminiscent of those reported in the fission yeast Schizosaccharomyces pombe, in which genetic deletion of AGO1 (the only Argonaute protein) or RDP1 (a homologue of RNA-dependent RNA polymerase) or DCR1 (a homologue of Dicer) leads to chromosome segregation defects and a reduced growth rate [40, 41]. RNAi has recently been shown to be functional in yeast . However, it has not been reported whether any of these three proteins are involved. Intriguingly, AGO1, RDP1 and DCR1 are all essential for heterochromatin formation at the centromere, transcriptional gene silencing of this same area and proper centromere function [16, 56]. It has been suggested that the RNAi machinery is required to process non-coding transcripts from the centromere, targeting these genomic sequences for formation of heterochromatin mediated by histone H3 methylation and recruiting Swi6/HP1 followed by cohesin protein complexes [16, 17, 57]. These results are also supported by the sequencing of yeast siRNAs, revealing a significant abundance of centromere-derived RNAs . Defects in heterochromatin formation at the centromere interfere with kinetochore and mitotic spindle formation, probably explaining the mitotic segregation defects reported [40, 41]. Interestingly, csp9, a fission yeast mutant impaired in chromosome segregation and transcriptional silencing at the centromere  turned out to be an allele of AGO1 (cited as personal communication by R.C. Allshire in ).
In T. brucei, one could imagine a similar involvement of the RNAi machinery in heterochromatin formation at the centromere, contribution to kinetochore assembly and chromosome segregation at mitosis. Unfortunately, centromeres have not yet been identified in trypanosomes and full sequencing and assembly of chromosomes I and II did not reveal any typical centromeric sequences [60, 61], thereby preventing direct testing of this hypothesis. One may wonder how the related kinetoplastid Leishmania behaves during mitosis, as the RNAi machinery appears to be absent . This situation is reminiscent of observations in yeast. Indeed, all the components of the RNAi machinery are present in fission yeast, whereas none of them have been found in budding yeast, although both genomes have been fully sequenced . This observation could be related to the striking difference between centromere structure in these two organisms . Similarly, trypanosomes and Leishmania separated a long time ago and could have developed separate systems to perform centromeric functions. Unfortunately the lack of information on centromere identity in both organisms prevents further investigation.
Finally, there is little information about heterochromatin structure in trypanosomes, despite the fact that it appears to play critical roles in the control of gene expression . Understanding the mechanisms of heterochromatin formation will no doubt be a crucial advance in unveiling the complex mechanisms of gene regulation in the Kinetoplastida.
We have identified novel Argonaute-like proteins in protozoa and demonstrated the essential role of one of them, TbAGO1, in RNAi in Trypanosoma brucei. Our data also reveal the importance of TbAGO1, probably via the RNAi machinery for proper chromosome segregation and spindle formation. Recent literature on the fission yeast S. pombe shows that AGO1 and two other components of the RNAi machinery are required for heterochromatin formation at the centromere and transcriptional gene silencing. Under these conditions, centromeres do not operate normally, leading to problems during mitosis. We postulate that a similar mechanism might operate in T. brucei, indicating the evolutionary ancient origin of Argonaute proteins involvement in RNAi and possibly in heterochromatin formation and centromere function.
The procyclic stage Trypanosoma brucei brucei strain 427 was used throughout this study. Cells were cultured at 27°C in semi-defined medium 79 containing 10 % foetal calf serum at densities of 1–8 million per ml. The PTH cell line that expresses the tet-repressor and allows tetracycline-inducible expression  was cultured under the same conditions.
Identification of Argonaute genes
The TIGR http://www.tigr.org/tdb/mdb/tbdb and Sanger Centre T. brucei databases http://www.sanger.ac.uk/Projects/T_brucei/, the L. major database http://www.sanger.ac.uk/Projects/L_major/, the T. cruzi database http://tcruzidb.org/, the P. falciparum database http://www.plasmodb.org/ and the G. lamblia database http://www.mbl.edu/Giardia were screened by BLAST search for the presence of Argonaute-like genes using the full-length sequence of the Paramecium PAP gene. Homologous sequences were identified and when required the genes were re-constructed. TbAGO1 and TbPWI1 were PCR-amplified using the high fidelity enzyme Pwo (Roche) and control-sequenced. Sequences were submitted to the GenBank database as AY433802 (TbAGO1) and AY433803 (TbPWI1).
Plasmid construction and mutant cell line generation
For expression of GFP::TbAGO1, a fusion gene was constructed in plasmid pGFPPFRC430 (P.B., unpublished). This plasmid is a derivative of pHD430  and contains the tetracycline-inducible EP1 promoter, followed by the EGFPN2 gene (Clontech) from which the stop codon was deleted, immediately followed by an XbaI site, in frame with the PFRC gene, followed by the 3' untranslated region of aldolase and by a cassette with the phleomycin gene resistance marker. The complete coding sequence of TbAGO1 was amplified by PCR with Pwo DNA polymerase (Roche) from genomic DNA using primers GCACGTCTAGAATGTCTGACTGGGAACGTGG (XbaI site underlined) and GCACGGGATCCTTATAGATAATGCATTGTTGT (Bam HI site underlined). The PCR product was cloned in pCR-Blunt-II-TOPO (Invitrogen) and the TbAGO1 coding sequence (including its stop codon) was cloned in frame with the EGFPN2 gene in the pGFPPFRC430 vector using Xba I and Bam HI sites to generate plasmid pGFPTbAGO1430. This plasmid was linearised with Eco RV and transformed in the PTH cell line that expresses the Tet-repressor  to generate a cell line that expresses the GFP::TbAGO1 fusion protein only in the presence of tetracycline (1 μg per ml).
For TbAGO1 gene deletion, TbAGO1 flanking sequences were amplified by PCR with Pfu DNA polymerase from genomic DNA using primers CGCCAACTGTACACTCGTATT and TTTATTTAAATCCTTTTTATTAAGTTGCTT (upstream region, amplifying a sequence of 500 bp terminating immediately ahead of TbAGO1 start codon) and ACCACCGCTTCTCCGGGGAAAGCAA and ACCACGAAACTCACACTGCTGTCAG (downstream region, amplifying a sequence of 453 bp, starting immediately downstream of TbAGO1 stop codon). The full coding sequences of gene resistance markers BSD and NEO were amplified with Pfu (Invitrogen) from plasmid DNA using primers ATGGCCAAGCCTTTGTCTCA and TTAGCCCTCCCACACATAAC (BSD) or ATGCGCGAAATCGTCTGCG and TCAGAAGAACTCGTCAAGAAGG (NEO). PCR products were ligated and re-amplified using the PCR-ligation protocol as described  with a few modifications. We used bolting primers CGCCAACTGTACACTCGTATT (upstream region, position in the sequence: -466) and GAAACTCACACTGCTGTCAGC (downstream region, position in the 3' flanking sequence: +448) for amplification after the second ligation. Final products used for transfection were therefore composed of 466 bp from the TbAGO1 upstream flanking region, the gene resistance marker BSD or NEO and 448 bp from the TbAGO1 downstream flanking region. First, the first allele of TbAGO1 was replaced by transformation of wild-type T. brucei (strain 427) with the BSD construct followed by selection with 10 μg/ml blasticidin (Sigma). Resistant cell lines were obtained at the expected frequency and further transformed with the NEO construct to replace the second TbAGO1 allele. Cells were selected with 10 μg/ml of blasticidin and 15 μg/ml of G418 (Calbiochem). Double resistant cells were obtained at the expected frequency and analysed by Southern blotting. A transformant cell line was selected, subcloned by limited dilution and termed TbAGO1-/- cell line.
For complementation, the TbAGO1-/- cell line was transformed with the pGFPTbAGO1430 plasmid and selected with 2 μg/ml phleomycin (Sigma), 10 μg/ml of blasticidin and 15 μg/ml of G418. Transformant cell lines were screened by FACS analysis detecting GFP fluorescence. To obtain tetracycline-regulatable expression of GFP::TbAGO1 in the knock-out background, this cell line was further transformed with plasmid pHD360 (linearised with Not I), that expresses the tet-repressor after integration in the tubulin locus . TbAGO1-/-+GFP::TbAGO1 Ticell lines were selected in the presence of 1 μg/ml tetracyline, 20 μg/ml hygromycin (Sigma), 2 μg/ml phleomycin, 10 μg/ml blasticidin and 15 μg/ml G418. Transformants were screened by FACS analysis before being grown in the absence of tetracycline to select cell lines with optimal control of expression. In all cases, cell lines were subcloned before any detailed analysis. For measurements of growth rates, cells were always grown without antibiotics (with the exception of tetracycline when required) for at least 7 days before the experiments and for the duration of the whole experiment.
RT-PCR, Northern and Southern blotting
RT-PCR was performed as described previously  using 250 ng of total RNA (DNA-free) and the following primers: ACGCCAAGCTTGGCGGTAGCGAAGACGCATTTG and GCACCCTCGAGACGCTCGTCGGATACTACCGCG (TbAGO1 segment from the nucleotide coding sequence 425 to 936); GCATCCAAGCTTCCATAGGTCGTTACTGTCG and CGTCGTCTCGAGCCACCGGAAGATGTGCCTGC (TbPWI1 segment from the nucleotide coding sequence 2228 to 2847). Northern blotting was carried out as described , except that DNA probes were radiolabelled by random priming. For Southern blotting, 20 μg genomic DNA was extracted from the various trypanosome cell lines and digested with the appropriate restriction enzymes, before separation on an 0.8 % agarose gel. Samples were transferred by capillarity to a HybondN+ (Amersham) membrane. The membrane was washed in 2x SSC, prehybridised in RapidHyb buffer (Amersham) at 65°C for 30 min and hybridised with radiolabelled probes overnight at 65°C. The membrane was washed twice for 5 min in 2x SSC and once for 20 min with 2x SSC, 0.1% SDS at 65°C. Radioactive signals were identified by Typhoon 9410 (Amersham) analysis and quantified using ImageQuant 5.2 software.
RNAi assays by transient transfection
RNA was synthesised in vitro with T3 and Sp6 polymerases using PCR products as templates. The following primers (incorporating T3 or Sp6 promoters) were used: for TbAGO1 (from the nucleotide coding sequence 604–903), AATTAACCCTCACTAAAGGGAGATCGTTGAACCCCAAAGAGAG (T3 promoter underlined) and ATTTAGGTGACACTATAGAAGAGCGCTCGCCGGATACTACCGC (Sp6 promoter underlined); for TbPWI1 (from the nucleotide coding sequence 2228–2848), AATTAACCCTCACTAAAGGGAGACCATAGGTCGTTACTGTCGT (T3 promoter underlined) and ATTTAGGTGACACTATAGAAGAGCCACCGGAAGATGTGCCTGC (Sp6 promoter underlined); for TbGRP1 (glycine-rich protein, from the nucleotide coding sequence 604–990), AATTAACCCTCACTAAAGGGAGACAGCGTGTGCAGGTGTCTGG (T3 promoter underlined) and ATTTAGGTGACACTATAGAAGAGCACCTTCTGACTGGCATCAC (Sp6 promoter underlined); for EGFPN2 (from the nucleotide coding sequence 476–691), AATTAACCCTCACTAAAGGGAGAAGAACGGCATCAAGGTGAAC (T3 promoter underlined) and ATTTAGGTGACACTATAGAAGAGTGATCCCGGCGGCGGTCACG (Sp6 promoter underlined) and finally PFRA (from the nucleotide coding sequence 1084–1358), ATTTAGGTGACACTATAGAGAGGTGAAGCGCCGTATTGAGGA (Sp6 promoter underlined) and AATTAACCCTCACTAAAGGGAGAGTTTTGTACAGGCGACGGAA (T3 promoter underlined). Amplified regions were selected to avoid cross-RNAi with any other sequence present in the T. brucei database . Single-stranded RNAs were mixed, heated at 90°C for 5 min and annealed in the RNA transcription buffer at 65°C for 30 min. Annealed dsRNA were sterilised by addition of 2.5 volumes of ethanol and 0.1 volume of 3 M sodium acetate (pH 5.0) followed by precipitation and resuspended in sterile water. Annealed dsRNA was introduced into trypanosomes by electroporation as described . For direct transfection assays, cells were transformed with PFRA, FLA1 or α-tubulin dsRNA, and returned to culture for 15–18 h before fixation and analysis by immunofluorescence. For dual transfection assays, cells were first electroporated with dsRNA from the gene to be tested, returned to culture for 10 hours and transfected with PFRA, FLA1 or tubulin dsRNA, grown for 15–18 h and processed as above. When GFP fluorescent proteins were used, cells were analysed by FACS (FACSort, Becton Dickinson) before transfection and immediately before fixation.
Immunofluorescence, FISH, image acquisition and analysis
For indirect immunofluorescence with the anti-PFRA specific monoclonal antibody L8C4  or with the anti-nucleolar antibody L1C6 (L. Kohl and K. Gull, University of Manchester, unpublished), cells were spread on poly-L-lysine coated slides and fixed in methanol at -20°C before processing as described . For indirect immunofluorescence with the anti-β tubulin monoclonal antibody KMX-1 , trypanosomes were fixed in 4 % (w/v) fresh paraformaldehyde in phosphate-buffered saline (PBS) at room temperature for 10 min, permeabilised for 10 minutes in 0.1 % Nonidet P-40 and processed as described . FISH was performed as described  except that probes were directly labelled with Alexa 546-dUTP (Molecular Probes). Slides were viewed using a DMR Leica microscope and images were captured with a Cool Snap HQ camera (Roper Scientific). Images were analysed using the IPLab Spectrum software (Scanalytics).
van der Krol AR, Mur LA, Beld M, Mol JN, Stuitje AR: Flavonoid genes in petunia: addition of a limited number of gene copies may lead to a suppression of gene expression. Plant Cell. 1990, 2: 291-299. 10.1105/tpc.2.4.291.
Cogoni C, Irelan JT, Schumacher M, Schmidhauser TJ, Selker EU, Macino G: Transgene silencing of the al-1 gene in vegetative cells of Neurospora is mediated by a cytoplasmic effector and does not depend on DNA-DNA interactions or DNA methylation. EMBO J. 1996, 15: 3153-3163.
Ruiz F, Vayssie L, Klotz C, Sperling L, Madeddu L: Homology-dependent gene silencing in Paramecium. Mol Biol Cell. 1998, 9: 931-943.
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998, 391: 806-811. 10.1038/35888.
Elbashir SM, Lendeckel W, Tuschl T: RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001, 15: 188-200. 10.1101/gad.862301.
Bernstein E, Caudy AA, Hammond SM, Hannon GJ: Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 2001, 409: 363-366. 10.1038/35053110.
Hutvagner G, Zamore PD: RNAi: nature abhors a double-strand. Curr Opin Genet Dev. 2002, 12: 225-232. 10.1016/S0959-437X(02)00290-3.
Mourrain P, Beclin C, Elmayan T, Feuerbach F, Godon C, Morel JB, Jouette D, Lacombe AM, Nikic S, Picault N, Remoue K, Sanial M, Vo TA, Vaucheret H: Arabidopsis SGS2 and SGS3 genes are required for posttranscriptional gene silencing and natural virus resistance. Cell. 2000, 101: 533-542.
Dalmay T, Hamilton A, Rudd S, Angell S, Baulcombe DC: An RNA-dependent RNA polymerase gene in Arabidopsis is required for posttranscriptional gene silencing mediated by a transgene but not by a virus. Cell. 2000, 101: 543-553.
Ketting RF, Haverkamp TH, van Luenen HG, Plasterk RH: Mut-7 of C. elegans, required for transposon silencing and RNA interference, is a homolog of Werner syndrome helicase and RNaseD. Cell. 1999, 99: 133-141.
Tabara H, Sarkissian M, Kelly WG, Fleenor J, Grishok A, Timmons L, Fire A, Mello CC: The rde-1 gene, RNA interference, and transposon silencing in C. elegans. Cell. 1999, 99: 123-132.
Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, Ha I, Baillie DL, Fire A, Ruvkun G, Mello CC: Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell. 2001, 106: 23-34.
Mochizuki K, Fine NA, Fujisawa T, Gorovsky MA: Analysis of a piwi-related gene implicates small RNAs in genome rearrangement in Tetrahymena. Cell. 2002, 110: 689-699.
Yao MC, Fuller P, Xi X: Programmed DNA deletion as an RNA-guided system of genome defense. Science. 2003, 300: 1581-1584. 10.1126/science.1084737.
Mette MF, Aufsatz W, van der Winden J, Matzke MA, Matzke AJ: Transcriptional silencing and promoter methylation triggered by double-stranded RNA. EMBO J. 2000, 19: 5194-5201. 10.1093/emboj/19.19.5194.
Volpe TA, Kidner C, Hall IM, Teng G, Grewal SI, Martienssen RA: Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science. 2002, 297: 1833-1837. 10.1126/science.1074973.
Schramke V, Allshire R: Hairpin RNAs and retrotransposon LTRs effect RNAi and chromatin-based gene silencing. Science. 2003, 301: 1069-1074. 10.1126/science.1086870.
Matthews KR: Developments in the differentiation of Trypanosoma brucei. Parasitol. Today. 1999, 15: 76-80. 10.1016/S0169-4758(98)01381-7.
Donelson JE: Antigenic variation and the African trypanosome genome. Acta Trop. 2003, 85: 391-404. 10.1016/S0001-706X(02)00237-1.
Bastin P, Sherwin T, Gull K: Paraflagellar rod is vital for trypanosome motility. Nature. 1998, 391: 548-10.1038/35300.
Ngô H, Tschudi C, Gull K, Ullu E: Double-stranded RNA induces mRNA degradation in Trypanosoma brucei. Proc Natl Acad Sci U S A. 1998, 95: 14687-14692. 10.1073/pnas.95.25.14687.
Bastin P, Ellis K, Kohl L, Gull K: Flagellum ontogeny studied via an inherited and regulated RNA interference system. J Cell Sci. 2000, 113: 3321-3328.
Wang Z, Morris JC, Drew ME, Englund PT: Interference of Trypanosoma brucei gene expression by RNA Interference using an integratable vector with opposing T7 promoters. J Biol Chem. 2000, 275: 40174-40179. 10.1074/jbc.M008405200.
Wang Z, Englund PT: RNA interference of a trypanosome topoisomerase II causes progressive loss of mitochondrial DNA. EMBO J. 2001, 20: 4674-4683. 10.1093/emboj/20.17.4674.
Morris JC, Wang Z, Drew ME, Englund PT: Glycolysis modulates trypanosome glycoprotein expression as revealed by an RNAi library. EMBO J. 2002, 21: 4429-4438. 10.1093/emboj/cdf474.
Kohl L, Robinson DR, Bastin P: Novel roles for the flagellum in cell morphogenesis and cytokinesis of trypanosomes. EMBO J. 2003, 22: 5336-5346. 10.1093/emboj/cdg518.
Djikeng A, Shi H, Tschudi C, Ullu E: RNA interference in Trypanosoma brucei: cloning of small interfering RNAs provides evidence for retroposon-derived 24–26-nucleotide RNAs. RNA. 2001, 7: 1522-1530.
Djikeng A, Shi H, Tschudi C, Shen S, Ullu E: An siRNA ribonucleoprotein is found associated with polyribosomes in Trypanosoma brucei. RNA. 2003, 9: 802-808. 10.1261/rna.5270203.
Robinson KA, Beverley SM: Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania. Mol Biochem Parasitol. 2003, 128: 217-228. 10.1016/S0166-6851(03)00079-3.
Cerutti L, Mian N, Bateman A: Domains in gene silencing and cell differentiation proteins: the novel PAZ domain and redefinition of the Piwi domain. Trends Biochem Sci. 2000, 25: 481-482. 10.1016/S0968-0004(00)01641-8.
Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ: Argonaute2, a link between genetic and biochemical analyses of RNAi. Science. 2001, 293: 1146-1150. 10.1126/science.1064023.
Durand-Dubief M, Kohl L, Bastin P: Efficiency and specificity of RNA interference generated by intra- and intermolecular double stranded RNA in Trypanosoma brucei. Mol Biochem Parasitol. 2003, 129: 11-21. 10.1016/S0166-6851(03)00071-9.
Cox DN, Chao A, Lin H: piwi encodes a nucleoplasmic factor whose activity modulates the number and division rate of germline stem cells. Development. 2000, 127: 503-514.
Wirtz E, Clayton C: Inducible gene expression in trypanosomes mediated by a prokaryotic repressor. Science. 1995, 268: 1179-1183.
Sherwin T, Gull K: The cell division cycle of Trypanosoma brucei brucei: timing of event markers and cytoskeletal modulations. Philos Trans R Soc Lond B Biol Sci. 1989, 323: 573-588.
Woodward R, Gull K: Timing of nuclear and kinetoplast DNA replication and early morphological events in the cell cycle of Trypanosoma brucei. J Cell Sci. 1990, 95: 49-57.
Robinson DR, Sherwin T, Ploubidou A, Byard EH, Gull K: Microtubule polarity and dynamics in the control of organelle positioning, segregation, and cytokinesis in the trypanosome cell cycle. J Cell Biol. 1995, 128: 1163-1172.
Ploubidou A, Robinson DR, Docherty RC, Ogbadoyi EO, Gull K: Evidence for novel cell cycle checkpoints in trypanosomes: kinetoplast segregation and cytokinesis in the absence of mitosis. J Cell Sci. 1999, 112: 4641-4650.
Ogbadoyi E, Ersfeld K, Robinson D, Sherwin T, Gull K: Architecture of the Trypanosoma brucei nucleus during interphase and mitosis. Chromosoma. 2000, 108: 501-513. 10.1007/s004120050402.
Provost P, Silverstein RA, Dishart D, Walfridsson J, Djupedal I, Kniola B, Wright A, Samuelsson B, Radmark O, Ekwall K: Dicer is required for chromosome segregation and gene silencing in fission yeast cells. Proc Natl Acad Sci U S A. 2002, 99: 16648-16653. 10.1073/pnas.212633199.
Hall IM, Noma K, Grewal SI: RNA interference machinery regulates chromosome dynamics during mitosis and meiosis in fission yeast. Proc Natl Acad Sci U S A. 2003, 100: 193-198. 10.1073/pnas.232688099.
Ersfeld K, Gull K: Partitioning of large and minichromosomes in Trypanosoma brucei. Science. 1997, 276: 611-614. 10.1126/science.276.5312.611.
Aravind L, Watanabe H, Lipman DJ, Koonin EV: Lineage-specific loss and divergence of functionally linked genes in eukaryotes. Proc Natl Acad Sci USA. 2000, 97: 11319-11324. 10.1073/pnas.200346997.
Doi N, Zenno S, Ueda R, Ohki-Hamazaki H, Ui-Tei K, Saigo K: Short-interfering-RNA-mediated gene silencing in mammalian cells requires Dicer and eIF2C translation initiation factors. Curr Biol. 2003, 13: 41-46. 10.1016/S0960-9822(02)01394-5.
Catalanotto C, Azzalin G, Macino G, Cogoni C: Gene silencing in worms and fungi. Nature. 2000, 404: 245-10.1038/35005169.
Das A, Peterson GC, Kanner SB, Frevert U, Parsons M: A major tyrosine-phosphorylated protein of Trypanosoma brucei is a nucleolar RNA-binding protein. J Biol Chem. 1996, 271: 15675-15681. 10.1074/jbc.271.28.16934.
Pelletier M, Miller MM, Read LK: RNA-binding properties of the mitochondrial Y-box protein RBP16. Nucleic Acids Res. 2000, 28: 1266-1275. 10.1093/nar/28.5.1266.
Pelletier M, Xu Y, Wang X, Zahariev S, Pongor S, Aletta JM, Read LK: Arginine methylation of a mitochondrial guide RNA binding protein from Trypanosoma brucei. Mol Biochem Parasitol. 2001, 118: 49-59. 10.1016/S0166-6851(01)00367-X.
Fagard M, Boutet S, Morel JB, Bellini C, Vaucheret H: AGO1, QDE-2, and RDE-1 are related proteins required for post-transcriptional gene silencing in plants, quelling in fungi, and RNA interference in animals. Proc Natl Acad Sci U S A. 2000, 97: 11650-11654. 10.1073/pnas.200217597.
Catalanotto C, Azzalin G, Macino G, Cogoni C: Involvement of small RNAs and role of the qde genes in the gene silencing pathway in Neurospora. Genes Dev. 2002, 16: 790-795. 10.1101/gad.222402.
Morel JB, Godon C, Mourrain P, Beclin C, Boutet S, Feuerbach F, Proux F, Vaucheret H: Fertile hypomorphic ARGONAUTE (ago1) mutants impaired in post-transcriptional gene silencing and virus resistance. Plant Cell. 2002, 14: 629-639. 10.1105/tpc.010358.
Li Z, Zou CB, Yao Y, Hoyt MA, McDonough S, Mackey ZB, Coffino P, Wang CC: An easily dissociated 26 S proteasome catalyzes an essential ubiquitin-mediated protein degradation pathway in Trypanosoma brucei. J Biol Chem. 2002, 277: 15486-15498. 10.1074/jbc.M109029200.
Hammarton TC, Clark J, Douglas F, Boshart M, Mottram JC: Stage-specific differences in cell cycle control in Trypanosoma brucei revealed by RNA interference of a mitotic cyclin. J Biol Chem. 2003, 278: 22877-22886. 10.1074/jbc.M300813200.
Li Z, Wang CC: A PHO80-like cyclin and a B-type cyclin control the cell cycle of the procyclic form of Trypanosoma brucei. J Biol Chem. 2003, 278: 20652-20658. 10.1074/jbc.M301635200.
Raponi M, Arndt GM: Double-stranded RNA-mediated gene silencing in fission yeast. Nucleic Acids Res. 2003, 31: 4481-4489. 10.1093/nar/gkg484.
Volpe T, Schramke V, Hamilton GL, White SA, Teng G, Martienssen RA, Allshire RC: RNA interference is required for normal centromere function in fission yeast. Chromosome Res. 2003, 11: 137-146. 10.1023/A:1022815931524.
Hall IM, Shankaranarayana GD, Noma K, Ayoub N, Cohen A, Grewal SI: Establishment and maintenance of a heterochromatin domain. Science. 2002, 297: 2232-2237. 10.1126/science.1076466.
Reinhart BJ, Bartel DP: Small RNAs correspond to centromere heterochromatic repeats. Science. 2002, 297: 1831-10.1126/science.1077183.
Ekwall K, Cranston G, Allshire RC: Fission yeast mutants that alleviate transcriptional gene silencing in centromeric flanking repeats and disrupts chromosome segregation. Genetics. 1999, 153: 1153-1169.
Hall N, Berriman M, Lennard NJ, Harris BR, Hertz-Fowler C, Bart-Delabesse EN, Gerrard CS, Atkin RJ, Barron AJ, Bowman S, Bray-Allen SP, Bringaud F, Clark LN, Corton CH, Cronin A, Davies R, Doggett J, Fraser A, Gruter E, Hall S, Harper AD, Kay MP, Leech V, Mayes R, Price C, Quail MA, Rabbinowitsch E, Reitter C, Rutherford K, Sasse J, Sharp S, Shownkeen R, MacLeod A, Taylor S, Tweedie A, Turner CM, Tait A, Gull K, Barrell B, Melville SE: The DNA sequence of chromosome I of an African trypanosome: gene content, chromosome organisation, recombination and polymorphism. Nucleic Acids Res. 2003, 31: 4864-4873. 10.1093/nar/gkg674.
El-Sayed NM, Ghedin E, Song J, MacLeod A, Bringaud F, Larkin C, Wanless D, Peterson J, Hou L, Taylor S, Tweedie A, Biteau N, Khalak HG, Lin X, Mason T, Hannick L, Caler E, Blandin G, Bartholomeu D, Simpson AJ, Kaul S, Zhao H, Pai G, Van Aken S, Utterback T, Haas B, Koo HL, Umayam L, Suh B, Gerrard C, Leech V, Qi R, Zhou S, Schwartz D, Feldblyum T, Salzberg S, Tait A, Turner CM, Ullu E, White O, Melville S, Adams MD, Fraser CM, Donelson JE: The sequence and analysis of Trypanosoma brucei chromosome II. Nucleic Acids Res. 2003, 31: 4856-4863. 10.1093/nar/gkg673.
Malik HS, Henikoff S: Conflict begets complexity: the evolution of centromeres. Curr Opin Genet Dev. 2002, 12: 711-718. 10.1016/S0959-437X(02)00351-9.
Navarro M, Cross GA, Wirtz E: Trypanosoma brucei variant surface glycoprotein regulation involves coupled activation/inactivation and chromatin remodeling of expression sites. EMBO J. 1999, 18: 2265-2272. 10.1093/emboj/18.8.2265.
Bastin P, MacRae TH, Francis SB, Matthews KR, Gull K: Flagellar morphogenesis: protein targeting and assembly in the paraflagellar rod of trypanosomes. Mol Cell Biol. 1999, 19: 8191-8200.
Ali SA, Steinkasserer A: PCR-ligation-PCR mutagenesis: a protocol for creating gene fusions and mutations. Biotechniques. 1995, 18: 746-750.
Kohl L, Sherwin T, Gull K: Assembly of the paraflagellar rod and the flagellum attachment zone complex during the Trypanosoma brucei cell cycle. J Eukaryot Microbiol. 1999, 46: 105-109.
Sherwin T, Schneider A, Sasse R, Seebeck T, Gull K: Distinct localization and cell cycle dependence of COOH terminally tyrosinolated alpha-tubulin in the microtubules of Trypanosoma brucei brucei. J Cell Biol. 1987, 104: 439-446.
Birkett CR, Foster KE, Johnson L, Gull K: Use of monoclonal antibodies to analyse the expression of a multi-tubulin family. FEBS Lett. 1985, 187: 211-218. 10.1016/0014-5793(85)81244-8.
We thank K. Gull and L. Kohl for providing the anti-nucleolar monoclonal antibody L1C6, C. Clayton for providing plasmids pHD360 and pHD430 and E. Charlier and H. Mitouard for technical assistance. We also wish to thank L. Kohl for help with sequence alignments and M. Gué for helpful discussion. Sequencing of T. brucei was carried out at TIGR and the Sanger Institute with support from NIAID and the Wellcome Trust, respectively. This work was funded by a CNRS ATIPE grant and by an "Aide à l'Implantation de Nouvelles Equipes" awarded by the Fondation pour la Recherche Médicale. M.D.-D is supported by a "Bourse de Formation Recherche du Gouvernement Luxembourgeois".
M.D.-D. carried out all the experiments reported including database searches. P.B. conceived the study, participated in its design and coordination and wrote the manuscript.
Electronic supplementary material
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.